{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-011738","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.531360+00:00","generated_at":"2026-06-06T20:38:16.558626+00:00","sec_items":["1.01","2.02","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CalciMedica raises up to $55M in private placement; $20.4M upfront from new and existing investors","bullets":["Upfront gross proceeds $20.4M from sale of 5.1M shares and pre-funded warrants to purchase 351,352 shares at $3.70/share.","Additional up to ~$34.2M possible if Tranche A ($5.36/share) and Tranche B ($7.15/share) warrants are exercised in cash.","Tranche A warrants expire earlier of 30 days after topline AP data or Dec 31, 2024; Tranche B earlier of 30 days after AKI data or Dec 31, 2026.","Cash, equivalents and short-term investments were $11.2M as of Dec 31, 2023 (preliminary); proceeds expected to fund Phase 2 trials in AP and AKI.","New investors include Deerfield Management, Soleus Capital, Stonepine Capital, Aisling Capital; JonesTrading as placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-011738","json":"https://secwatch.observer/filing/0001193125-24-011738.json","markdown":"https://secwatch.observer/filing/0001193125-24-011738.md","text":"https://secwatch.observer/filing/0001193125-24-011738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/0001193125-24-011738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:38:16.558626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d84ca4c954c2cb7f30961867ffc354b24be39122","claim":"CalciMedica, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at upfront gross proceeds from the Private Placement of $20.4 million (effective 2024-01-19).","evidence_excerpt":"On January 19, 2024, CalciMedica, Inc. (the “Company”) and certain accredited investors (each an “Investor” and collectively, the “Investors”) entered into a securities purchase agreement (the “Securities Purchase Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/0001193125-24-011738-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"upfront gross proceeds from the Private Placement of $20.4 million"},{"label":"Effective","value":"2024-01-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}